pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,551
stories
Sep 24, 26
US senators grill FDA nominee Overton on ability to ‘stand up’ to Trump
biospace
Sep 24, 26
Elevar wins first FDA approval with second-line drug for bile duct cancer
endpoints
Sep 24, 26
Chutes & Ladders—Travere chief makes way for former Amicus CEO
fiercebiotech
Sep 24, 26
Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearing
fiercebiotech
Sep 24, 26
STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit
stat
Sep 24, 26
Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data
biospace
Sep 24, 26
Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry
biospace
Sep 24, 26
China’s Henlius carves out $440M T-cell engager deal with Amberstone
fiercebiotech
Sep 24, 26
Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T
endpoints
Sep 24, 26
STAT+: Momentum is building for a big change to how doctors get paid
stat
Sep 24, 26
Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
fiercebiotech
Sep 24, 26
Adagio Medical kicks off strategic review, trims more than half its staff
fiercebiotech
Sep 24, 26
Growth mode: 3 biotechs that are staffing up after series B raises
biospace
Sep 24, 26
Grail survives adcomm vote as it awaits FDA decision for cancer blood test
fiercebiotech
Sep 24, 26
Euro Roundup: EMA officials argue against making single pivotal trials the ‘rigid, default position’
raps
Sep 23, 26
FDA adcomm votes in favor of benefit-risk of Grail’s cancer test
endpoints
Sep 23, 26
Roche, Ionis RNA drug scores in kidney disease study
biopharma dive
Sep 23, 26
New approach methodologies in safety and toxicology testing: Why proving repeatability is the next hurdle for widespread adoption
fiercebiotech
Sep 23, 26
Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren's study
biospace
Sep 23, 26
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
biospace
Sep 23, 26
STAT+: Flagship gets a Pentagon contract
stat
Sep 23, 26
STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and more
stat
Sep 23, 26
Novartis bets up to $900M for radioligand therapy from China’s BoomRay
biospace
Sep 23, 26
Ionis-Otsuka offer 'groundbreaking' improvement in function and survival for genetic type of ALS
biospace
Sep 23, 26
Roche kidney drug's Phase 3 win sets up path to accelerated approval
endpoints
Sep 23, 26
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
Sep 23, 26
STAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?
stat
Sep 23, 26
STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
stat
Sep 23, 26
ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s hands
biospace
Sep 23, 26
China’s surging biotech sector represents both competition and lifeline for the US
biospace
← prev
page 18 of 52
next →